-transparent.png){kind=logo}
Diazoxide was given orally to nine hypertensive patients with renal failure and its effect on blood pressure and on glucose metabolism was studied. There was no long-term antihypertensive effect. During treatment insulin release and glucose assimilation after an intravenous glucose load were frankly impaired, but this impairment was reversible after stopping the treatment. Two major complications (diabetic ketoacidosis and pancreatitis) were observed. In view of these observations, the authors are of the opinion that oral diazoxide is contraindicated in the treatment of hypertension in patients with renal failure.
Related Publications
M M Mussche, and
M E De Broe, and
F M Belpaire, and
A Vermeulen, and
S M Ringoir
October 1971,
British medical journal,
M M Mussche, and
M E De Broe, and
F M Belpaire, and
A Vermeulen, and
S M Ringoir
July 1975,
Danish medical bulletin,
M M Mussche, and
M E De Broe, and
F M Belpaire, and
A Vermeulen, and
S M Ringoir
January 1976,
Lakartidningen,
M M Mussche, and
M E De Broe, and
F M Belpaire, and
A Vermeulen, and
S M Ringoir
August 1973,
Clinical science and molecular medicine. Supplement,
M M Mussche, and
M E De Broe, and
F M Belpaire, and
A Vermeulen, and
S M Ringoir
January 1978,
The Netherlands journal of medicine,
M M Mussche, and
M E De Broe, and
F M Belpaire, and
A Vermeulen, and
S M Ringoir
December 1972,
Clinical science,
M M Mussche, and
M E De Broe, and
F M Belpaire, and
A Vermeulen, and
S M Ringoir
January 1971,
Drugs,
M M Mussche, and
M E De Broe, and
F M Belpaire, and
A Vermeulen, and
S M Ringoir
January 1981,
Cardiovascular clinics,
M M Mussche, and
M E De Broe, and
F M Belpaire, and
A Vermeulen, and
S M Ringoir
November 1976,
Harefuah,
M M Mussche, and
M E De Broe, and
F M Belpaire, and
A Vermeulen, and
S M Ringoir
February 1972,
Gaceta medica de Mexico,
